These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34900743)

  • 1. Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis.
    Polesel J; Menegaldo A; Tirelli G; Giacomarra V; Guerrieri R; Baboci L; Casarotto M; Lupato V; Fanetti G; Boscolo-Rizzo P; Fratta E
    Front Oncol; 2021; 11():787864. PubMed ID: 34900743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma.
    Zhu Y; Zhu X; Diao W; Liang Z; Gao Z; Chen X
    Clin Oral Investig; 2023 Apr; 27(4):1423-1433. PubMed ID: 36884083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 Expression and a High Tumor Infiltrate of CD8+ Lymphocytes Predict Outcome in Patients with Oropharyngeal Squamous Cells Carcinoma.
    Wuerdemann N; Gültekin SE; Pütz K; Wittekindt C; Huebbers CU; Sharma SJ; Eckel H; Schubotz AB; Gattenlöhner S; Büttner R; Speel EJ; Klussmann JP; Wagner S; Quaas A
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ T Cells and PD-L1 Expression as Prognostic Indicators in a Low Prevalence of HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Atipas K; Laokulrath N; Petsuksiri J; Ratanaprasert N; Pongsapich W
    Curr Oncol; 2023 Jan; 30(2):1450-1460. PubMed ID: 36826072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma.
    Gurin D; Slavik M; Hermanova M; Selingerova I; Kazda T; Hendrych M; Shatokhina T; Vesela M
    J Oral Pathol Med; 2020 Oct; 49(9):886-896. PubMed ID: 32516834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis and Clinical Implication of PD-L1 Expression Considering HPV Status in Oropharyngeal Squamous Cell Carcinoma.
    Jeong JY; Park TI; Ahn D
    Anticancer Res; 2020 Jul; 40(7):4001-4010. PubMed ID: 32620644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression.
    Xu SM; Shi CJ; Xia RH; Wang LZ; Tian Z; Ye WM; Liu L; Liu SL; Zhang CY; Hu YH; Zhou R; Han Y; Wang Y; Zhang ZY; Li J
    Front Immunol; 2021; 12():798424. PubMed ID: 35145511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant association of PD-L1 expression with human papillomavirus positivity and its prognostic impact in oropharyngeal cancer.
    Hong AM; Ferguson P; Dodds T; Jones D; Li M; Yang J; Scolyer RA
    Oral Oncol; 2019 May; 92():33-39. PubMed ID: 31010620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of p16 and PD-L1 expression in patients with oropharyngeal squamous cell carcinoma receiving a definitive treatment.
    Sato F; Ono T; Kawahara A; Kawaguchi T; Tanaka H; Shimamatsu K; Kakuma T; Akiba J; Umeno H; Yano H
    J Clin Pathol; 2019 Aug; 72(8):542-549. PubMed ID: 31113825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking.
    Lilja-Fischer JK; Eriksen JG; Georgsen JB; Vo TT; Larsen SR; Cheng J; Busch-Sørensen M; Aurora-Garg D; Steiniche T; Overgaard J
    Acta Oncol; 2020 Jun; 59(6):666-672. PubMed ID: 32079442
    [No Abstract]   [Full Text] [Related]  

  • 12. PD-L1 immunohistochemical expression considering HPV status in oropharyngeal squamous cell carcinoma.
    Anjos RSD; Carvalho MV; Costa RTF; Vasconcelos BCDE; Moraes SLD; Pellizzer EP
    Braz Oral Res; 2024; 38():e095. PubMed ID: 39356903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The different role of PD-L1 in head and neck squamous cell carcinomas: A meta-analysis.
    Tang H; Zhou X; Ye Y; Zhou Y; Wu C; Xu Y
    Pathol Res Pract; 2020 Jan; 216(1):152768. PubMed ID: 31837884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: a meta analysis].
    Yuanyuan X; Suling H; Quan Z; Shixun Z; Yucheng Y; Houyong K; Guohua H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Mar; 50(3):236-43. PubMed ID: 26268498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis.
    Xu Y; Zhu G; Maroun CA; Wu IXY; Huang D; Seiwert TY; Liu Y; Mandal R; Zhang X
    Front Immunol; 2021; 12():645170. PubMed ID: 33897693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 expression in anogenital and oropharyngeal squamous cell carcinomas associated with different clinicopathological features, HPV status and prognosis: a meta-analysis.
    Qin Y; Luan J; Zhou X; Li Y
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33704390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors.
    Stern PL; Dalianis T
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34202255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
    Wang MB; Liu IY; Gornbein JA; Nguyen CT
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma.
    Steuer CE; Griffith CC; Nannapaneni S; Patel MR; Liu Y; Magliocca KR; El-Deiry MW; Cohen C; Owonikoko TK; Shin DM; Chen ZG; Saba NF
    Mol Cancer Ther; 2018 Mar; 17(3):710-716. PubMed ID: 29440293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.